Literature DB >> 31680682

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing.

Shailesh K Shahi1, Kasra Zarei2, Natalya V Guseva1, Ashutosh K Mangalam3.   

Abstract

The human gut is colonized by trillions of bacteria that support physiologic functions such as food metabolism, energy harvesting, and regulation of the immune system. Perturbation of the healthy gut microbiome has been suggested to play a role in the development of inflammatory diseases, including multiple sclerosis (MS). Environmental and genetic factors can influence the composition of the microbiome; therefore, identification of microbial communities linked with a disease phenotype has become the first step towards defining the microbiome's role in health and disease. Use of 16S rRNA metagenomic sequencing for profiling bacterial community has helped in advancing microbiome research. Despite its wide use, there is no uniform protocol for 16S rRNA-based taxonomic profiling analysis. Another limitation is the low resolution of taxonomic assignment due to technical difficulties such as smaller sequencing reads, as well as use of only forward (R1) reads in the final analysis due to low quality of reverse (R2) reads. There is need for a simplified method with high resolution to characterize bacterial diversity in a given biospecimen. Advancements in sequencing technology with the ability to sequence longer reads at high resolution have helped to overcome some of these challenges. Present sequencing technology combined with a publicly available metagenomic analysis pipeline such as R-based Divisive Amplicon Denoising Algorithm-2 (DADA2) has helped advance microbial profiling at high resolution, as DADA2 can assign sequence at the genus and species levels. Described here is a guide for performing bacterial profiling using two-step amplification of the V3-V4 region of the 16S rRNA gene, followed by analysis using freely available analysis tools (i.e., DADA2, Phyloseq, and METAGENassist). It is believed that this simple and complete workflow will serve as an excellent tool for researchers interested in performing microbiome profiling studies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31680682      PMCID: PMC6945761          DOI: 10.3791/59980

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  49 in total

1.  Evaluating different approaches that test whether microbial communities have the same structure.

Authors:  Patrick D Schloss
Journal:  ISME J       Date:  2008-01-31       Impact factor: 10.302

Review 2.  The intestinal epithelial barrier in the control of homeostasis and immunity.

Authors:  Maria Rescigno
Journal:  Trends Immunol       Date:  2011-05-11       Impact factor: 16.687

Review 3.  Influence and effect of the human microbiome in allergy and asthma.

Authors:  Ariane R Panzer; Susan V Lynch
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

Review 4.  Microbiome-Modulated Metabolites at the Interface of Host Immunity.

Authors:  Eran Blacher; Maayan Levy; Evgeny Tatirovsky; Eran Elinav
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

Review 5.  Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.

Authors:  Francesca Pistollato; Sandra Sumalla Cano; Iñaki Elio; Manuel Masias Vergara; Francesca Giampieri; Maurizio Battino
Journal:  Nutr Rev       Date:  2016-10       Impact factor: 7.110

Review 6.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

Review 7.  Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease.

Authors:  Muhammad I Naseer; Fehmida Bibi; Mohammed H Alqahtani; Adeel G Chaudhary; Esam I Azhar; Mohammad A Kamal; Muhammad Yasir
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

Review 8.  Regulation of innate and adaptive immunity by the commensal microbiota.

Authors:  Irene Jarchum; Eric G Pamer
Journal:  Curr Opin Immunol       Date:  2011-04-03       Impact factor: 7.486

Review 9.  Experimental and analytical tools for studying the human microbiome.

Authors:  Justin Kuczynski; Christian L Lauber; William A Walters; Laura Wegener Parfrey; José C Clemente; Dirk Gevers; Rob Knight
Journal:  Nat Rev Genet       Date:  2011-12-16       Impact factor: 53.242

Review 10.  Analysing Microbial Community Composition through Amplicon Sequencing: From Sampling to Hypothesis Testing.

Authors:  Luisa W Hugerth; Anders F Andersson
Journal:  Front Microbiol       Date:  2017-09-04       Impact factor: 5.640

View more
  12 in total

1.  The Effects of Benoxacor on the Liver and Gut Microbiome of C57BL/6 Mice.

Authors:  Derek Simonsen; Nicole Cady; Chunyun Zhang; Rachel L Shrode; Michael L McCormick; Douglas R Spitz; Michael S Chimenti; Kai Wang; Ashutosh Mangalam; Hans-Joachim Lehmler
Journal:  Toxicol Sci       Date:  2022-02-28       Impact factor: 4.109

2.  Toll-like receptor 4 and myeloid differentiation factor 88 are required for gastric bypass-induced metabolic effects.

Authors:  Marwa Abu El Haija; Yuanchao Ye; Yi Chu; Hussein Herz; Benjamin Linden; Shailesh K Shahi; Kasra Zarei; Ashutosh K Mangalam; Steven J Mcelroy; Mohamad Mokadem
Journal:  Surg Obes Relat Dis       Date:  2021-08-02       Impact factor: 3.709

3.  HLA Class II Polymorphisms Modulate Gut Microbiota and Experimental Autoimmune Encephalomyelitis Phenotype.

Authors:  Shailesh K Shahi; Soham Ali; Camille M Jaime; Natalya V Guseva; Ashutosh K Mangalam
Journal:  Immunohorizons       Date:  2021-08-11

4.  Metagenomic analysis of intestinal microbiota in wild rats living in urban and rural habitats.

Authors:  Rafig Gurbanov; Uygar Kabaoğlu; Tuba Yağcı
Journal:  Folia Microbiol (Praha)       Date:  2022-01-31       Impact factor: 2.099

5.  Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.

Authors:  Meeta Yadav; Soham Ali; Rachel L Shrode; Shailesh K Shahi; Samantha N Jensen; Jemmie Hoang; Samuel Cassidy; Heena Olalde; Natalya Guseva; Mishelle Paullus; Catherine Cherwin; Kai Wang; Tracey Cho; John Kamholz; Ashutosh K Mangalam
Journal:  PLoS One       Date:  2022-04-26       Impact factor: 3.752

6.  Secreted osteopontin from CD4+ T cells limits acute graft-versus-host disease.

Authors:  Nupur Aggarwal; M Elizabeth Deerhake; Devon DiPalma; Shailesh K Shahi; Margaret R Gaggioli; Ashutosh K Mangalam; Mari L Shinohara
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.995

7.  Longitudinal study of the vaginal microbiome in pregnancies involving preterm labor.

Authors:  Yoshiko Sakabe; Haruki Nishizawa; Asuka Kato; Yoshiteru Noda; Akiko Ohwaki; Hikari Yoshizawa; Takema Kato; Takao Sekiya; Takuma Fujii; Hiroki Kurahashi
Journal:  Fujita Med J       Date:  2021-11-25

8.  Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function.

Authors:  Yuan-Wei Zhang; Mu-Min Cao; Ying-Juan Li; Pan-Pan Lu; Guang-Chun Dai; Ming Zhang; Hao Wang; Yun-Feng Rui
Journal:  J Orthop Translat       Date:  2022-09-26       Impact factor: 4.889

9.  Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.

Authors:  Justin Chau; Meeta Yadav; Ben Liu; Muhammad Furqan; Qun Dai; Shailesh Shahi; Arnav Gupta; Keri Nace Mercer; Evan Eastman; Taher Abu Hejleh; Carlos Chan; George J Weiner; Catherine Cherwin; Sonny T M Lee; Cuncong Zhong; Ashutosh Mangalam; Jun Zhang
Journal:  BMC Cancer       Date:  2021-07-13       Impact factor: 4.430

10.  Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis.

Authors:  Samantha N Jensen; Nicole M Cady; Shailesh K Shahi; Stephanie R Peterson; Arnav Gupta; Katherine N Gibson-Corley; Ashutosh K Mangalam
Journal:  Sci Adv       Date:  2021-07-09       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.